Prostate Cancer - Results from #26620

Percentage of positive biopsy cores: A better risk stratification model for prostate cancer? - Abstract December 22, 2011

Prostatic carcinomas with neuroendocrine differentiation diagnosed in needle biopsies, a morphologic study of 7 cases among 465 sequential biopsies in a tertiary cancer center - Abstract December 22, 2011

Performance characteristics of computed tomography in detecting lymph node metastases in contemporary patients with prostate cancer treated with extended pelvic lymph node dissection - Abstract December 22, 2011

Obesity is associated with castration-resistant disease and metastasis in men treated with androgen deprivation therapy after radical prostatectomy: Results from the SEARCH database - Abstract December 21, 2011

Ciprofloxacin as a prophylactic agent against prostate cancer: A "two hit" hypothesis - Abstract December 21, 2011

Methods of verifying the output of the treatment planning system used for high dose rate (HDR) prostate brachytherapy - Abstract December 21, 2011

Indications for pelvic nodal treatment in prostate cancer should change. Validation of the Roach formula in a large extended nodal dissection series - Abstract December 21, 2011

Intensity-modulated radiotherapy causes fewer side effects than three-dimensional conformal radiotherapy when used in combination with brachytherapy for the treatment of prostate cancer - Abstract December 21, 2011

Detection, localisation and characterisation of prostate cancer by Prostate HistoScanning™ - Abstract December 20, 2011

New treatment paradigm for prostate cancer: Abarelix initiation therapy for immediate testosterone suppression followed by a luteinizing hormone-releasing hormone agonist - Abstract December 20, 2011

African American men significantly underestimate their risk of having prostate cancer at the time of biopsy - Abstract December 20, 2011

Updating risk prediction tools: A case study in prostate cancer - Abstract December 20, 2011

BJUI Mini Reviews - Prostatic intraepithelial neoplasia: Its morphological and molecular diagnosis and clinical significance December 20, 2011

Antiangiogenic Thrombospondin-1 triggers cell migration and development of advanced prostate tumors December 19, 2011

Prognostic significance of neuroendocrine differentiation in prostate adenocarcinoma December 19, 2011

Pathological stage distribution in patients treated with radical prostatectomy reflecting the need for protocol-based active surveillance: Results from a contemporary European patient cohort - Abstract December 19, 2011

Effect of delaying surgery on radical prostatectomy outcomes: A contemporary analysis - Abstract December 19, 2011

From image-guided radiotherapy to dose-guided radiotherapy - Abstract December 19, 2011

The importance of an exponential prostate-specific antigen decline after external beam radiotherapy for intermediate risk prostate cancer - Abstract December 19, 2011

Alcohol consumption and prostate cancer risk: A meta-analysis of the dose-risk relation - Abstract December 19, 2011

Page 1332 of 1437